Ovo Labs

Ovo Labs is developing therapeutics that boost egg quality to enhance IVF success. Their technology aims to extend the period during which the chances of conception remain high. They are currently advancing three egg rejuvenation therapeutics through preclinical development toward clinical application.

Together, these therapeutics have the potential to increase IVF success rates by 20–30% for women under 35 and by three- to fivefold for women aged 35–45.